NCT06187402 - A Study of LM-24C5 For Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 30, 2026

Conditions

Advanced Solid Tumor

Interventions

DRUG

LM-24C5

Administered intravenously

Trial Locations (6)

NOT_YET_RECRUITING

Virginia Cancer Specialists, P.C., Fairfax

RECRUITING

Ocala Oncology, Ocala

NOT_YET_RECRUITING

The Christ Hospital, Cincinnati

NOT_YET_RECRUITING

Indiana University Melvan and Bren Simon Cancer Center, Indianapolis

NOT_YET_RECRUITING

Mary Crowley Cancer Research Center, Dallas

NOT_YET_RECRUITING

University of Southern California (USC) - Norris Comprehensive Cancer Center, Los Angeles